3,877
Views
25
CrossRef citations to date
0
Altmetric
Research Article

Toxicological Implications of Nasal Formulations

, &
Pages 227-242 | Published online: 29 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Rosamaria Lombardo, Teresa Musumeci, Claudia Carbone & Rosario Pignatello. (2021) Nanotechnologies for intranasal drug delivery: an update of literature. Pharmaceutical Development and Technology 26:8, pages 824-845.
Read now
Ben Forbes, Rene Bommer, Jonathan Goole, Marie Hellfritzsch, Wilbur De Kruijf, Pierre Lambert, Grazia Caivano, Alain Regard, Francesca Schiaretti, Marie Trenkel, Laurent Vecellio, Gerallt Williams, Fabio Sonvico & Regina Scherließ. (2020) A consensus research agenda for optimising nasal drug delivery. Expert Opinion on Drug Delivery 17:2, pages 127-132.
Read now

Articles from other publishers (23)

Someshbabu Ramesh Babu, Harshith Hosahalli Shekara, Ashish Kumar Sahoo, Pyda Venkata Harsha Vardhan, Nitheesh Thiruppathi & Madhugiri Prakash Venkatesh. (2023) Intranasal nanoparticulate delivery systems for neurodegenerative disorders: a review. Therapeutic Delivery 14:9, pages 571-594.
Crossref
Muhammad Usman Khan, Xinyu Cai, Zhiwei Shen, Taye Mekonnen, Agisilaos Kourmatzis, Shaokoon Cheng & Hanieh Gholizadeh. (2023) Challenges in the Development and Application of Organ-on-Chips for Intranasal Drug Delivery Studies. Pharmaceutics 15:5, pages 1557.
Crossref
Bin Tu, Yanrong Gao, Xinran An, Huiyuan Wang & Yongzhuo Huang. (2023) Localized delivery of nanomedicine and antibodies for combating COVID-19. Acta Pharmaceutica Sinica B 13:5, pages 1828-1846.
Crossref
Cinzia Pagano, Luana Perioli & Maurizio Ricci. 2023. Nasal Drug Delivery. Nasal Drug Delivery 235 252 .
Lea-Adriana Keller, Olivia Merkel & Andreas Popp. (2021) Intranasal drug delivery: opportunities and toxicologic challenges during drug development. Drug Delivery and Translational Research 12:4, pages 735-757.
Crossref
Desiree Schütz, Carina Conzelmann, Giorgio Fois, Rüdiger Groß, Tatjana Weil, Lukas Wettstein, Steffen Stenger, Alexander Zelikin, Thomas K. Hoffmann, Manfred Frick, Janis A. Müller & Jan Münch. (2021) Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures. American Journal of Physiology-Lung Cellular and Molecular Physiology 320:5, pages L750-L756.
Crossref
Hetal Thakkar, Darshan Vaghela & Brijesh Pradipkumar Patel. (2021) Brain targeted intranasal in-situ gelling spray of paroxetine: Formulation, characterization and in-vivo evaluation". Journal of Drug Delivery Science and Technology 62, pages 102317.
Crossref
Mrunal Patil. 2021. Direct Nose-to-Brain Drug Delivery. Direct Nose-to-Brain Drug Delivery 115 156 .
Mukta Agrawal, Shailendra Saraf, Swarnlata Saraf, Sunil K. Dubey, Anu Puri, Umesh Gupta, Prashant Kesharwani, V. Ravichandiran, Pramod Kumar, V.G.M. Naidu, Upadhyayula Suryanarayana Murty, Ajazuddin & Amit Alexander. (2020) Stimuli-responsive In situ gelling system for nose-to-brain drug delivery. Journal of Controlled Release 327, pages 235-265.
Crossref
Samantha Frank, Seth M. Brown, Joseph A. Capriotti, Jonna B. Westover, Jesse S. Pelletier & Belachew Tessema. (2020) In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2. JAMA Otolaryngology–Head & Neck Surgery 146:11, pages 1054.
Crossref
Regina Scherließ. (2020) Nasal formulations for drug administration and characterization of nasal preparations in drug delivery. Therapeutic Delivery 11:3, pages 183-191.
Crossref
Serdar Sezer, İsa Şahin, Kevser Öztürk, Vildan Şanko, Zeynep Koçer & Ümran Aydemir Sezer. 2019. Cellulose-Based Superabsorbent Hydrogels. Cellulose-Based Superabsorbent Hydrogels 1177 1203 .
Serdar Sezer, İsa Şahin, Kevser Öztürk, Vildan Şanko, Zeynep Koçer & Ümran Aydemir Sezer. 2018. Cellulose-Based Superabsorbent Hydrogels. Cellulose-Based Superabsorbent Hydrogels 1 27 .
R Bhat, Z. Abbas & N.G.N. Swamy. (2013) THERMOREVERSIBLE, MUCOADHESIVE IN SITU GELLING FORMULATIONS FOR NASAL DELIVERY OF PROPRANOLOL HYDROCHLORIDE. INDIAN DRUGS 50:09, pages 41-51.
Crossref
Ratnesh Jain, Swapna Nabar, Prajakta Dandekar & Vandana Patravale. (2010) Micellar Nanocarriers: Potential Nose-to-Brain Delivery of Zolmitriptan as Novel Migraine Therapy. Pharmaceutical Research 27:4, pages 655-664.
Crossref
Neil R. Mathias, Paul Moench, Christopher Heran, Munir A. Hussain & Ronald L. Smith. (2009) Rat Nasal Lavage Biomarkers to Assess Preclinical Irritation Potential of Nasal Drug Formulations and Excipients. Journal of Pharmaceutical Sciences 98:2, pages 495-502.
Crossref
. 2007. Advanced Drug Formulation Design to Optimize Therapeutic Outcomes. Advanced Drug Formulation Design to Optimize Therapeutic Outcomes 301 322 .
E. Gilat, T. Kadar, A. Levy, I. Rabinovitz, G. Cohen, Y. Kapon, R. Sahar & R. Brandeis. (2005) Anticonvulsant treatment of sarin-induced seizures with nasal midazolam: An electrographic, behavioral, and histological study in freely moving rats. Toxicology and Applied Pharmacology 209:1, pages 74-85.
Crossref
M.G. Soni, I.G. Carabin & G.A. Burdock. (2005) Safety assessment of esters of p-hydroxybenzoic acid (parabens). Food and Chemical Toxicology 43:7, pages 985-1015.
Crossref
E. Gilat, M. Goldman, E. Lahat, A. Levy, I. Rabinovitz, G. Cohen, R. Brandeis, G. Amitai, D. Alkalai & G. Eshel. (2002) Nasal midazolam as a novel anticonvulsive treatment against organophosphate-induced seizure activity in the guinea pig. Archives of Toxicology 77:3, pages 167-172.
Crossref
Stanley S Davis & Lisbeth Illum. (2003) Absorption Enhancers for Nasal Drug Delivery. Clinical Pharmacokinetics 42:13, pages 1107-1128.
Crossref
M.G. Soni, S.L. Taylor, N.A. Greenberg & G.A. Burdock. (2002) Evaluation of the health aspects of methyl paraben: a review of the published literature. Food and Chemical Toxicology 40:10, pages 1335-1373.
Crossref
H.O Alpar, J.E Eyles, E.D Williamson & S Somavarapu. (2001) Intranasal vaccination against plague, tetanus and diphtheria. Advanced Drug Delivery Reviews 51:1-3, pages 173-201.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.